$25.80
At close: Apr 7, 9:34 AM EDT
Comments
Loading...
Swedish Orphan Biovitrum Analyst Ratings and Price Targets | OTC:BIOVF | Benzinga
Swedish Orphan Biovitrum Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Swedish Orphan Biovitrum Corp from these most-recent analyst ratings.
Analyst Ratings for Swedish Orphan Biovitrum
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Swedish Orphan Biovitrum (BIOVF) stock?
There is no price target for Swedish Orphan Biovitrum
What is the most recent analyst rating for Swedish Orphan Biovitrum (BIOVF)?
There is no analyst for Swedish Orphan Biovitrum
When was the last upgrade for Swedish Orphan Biovitrum (BIOVF)?
There is no last upgrade for Swedish Orphan Biovitrum
When was the last downgrade for Swedish Orphan Biovitrum (BIOVF)?
There is no last downgrade for Swedish Orphan Biovitrum.
When is the next analyst rating going to be posted or updated for Swedish Orphan Biovitrum (BIOVF)?
There is no next analyst rating for Swedish Orphan Biovitrum.
Is the Analyst Rating Swedish Orphan Biovitrum (BIOVF) correct?
There is no next analyst rating for Swedish Orphan Biovitrum.
Browse analyst ratings and price targets on all stocks.